Journal article
Urokinase-type plasminogen activator and arthritis progression: Contrasting roles in systemic and monoarticular arthritis models
CM De Nardo, JC Lenzo, J Pobjoy, JA Hamilton, AD Cook
Arthritis Research and Therapy | BMC | Published : 2010
DOI: 10.1186/ar3171
Open access
Abstract
Introduction: Urokinase-type plasminogen activator (u-PA) has been implicated in tissue destruction/remodeling. The absence of u-PA results in resistance of mice to systemic immune complex-driven arthritis models; monoarticular arthritis models involving an intra-articular (i.a.) antigen injection, on the other hand, develop more severe arthritis in its absence. The aims of the current study are to investigate further these contrasting roles that u-PA can play in the pathogenesis of inflammatory arthritis and to determine whether u-PA is required for the cartilage and bone destruction associated with disease progression.Methods: To determine how the different pathogenic mechanisms leading to..
View full abstractGrants
Funding Acknowledgements
We thank Peter Carmeliet for the mice, Jennifer Davis for their maintenance and care, and Amanda J Fosang for the antibody against DIPEN. This work was supported by a Program Grant and a Senior Principal Research Fellowship (JAH) from the National Health and Medical Research Council of Australia.